Navigation Links
Pharmaxis Launches ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
Date:2/23/2011

of ARIDOL as a bronchial challenge test were verified in two global Phase III clinical trials, which assessed the effectiveness of the ARIDOL bronchial challenge test in non-asthmatic patients with symptoms suggestive of asthma and clinically diagnosed asthmatic patients six years of age and older.  Approved for use in 19 countries, ARIDOL has been used by more than 44,000 patients, and is marketed in Australia, major European countries and Korea.  ARIDOL is included in official international guidelines for the clinical assessment of asthma. Organizations and guidelines endorsing ARIDOL include: the International Olympic Committee Medical Commission's Independent Panel on Asthma, the U.S. Asthma Management Guidelines, the Global Initiative for Asthma (GINA) Report on Global Strategy for Asthma Management and Prevention, the World Anti-Doping Agency and the Australian Asthma Management Handbook. ARIDOL is the only dry powder bronchial challenge test approved for use in the U.S.

Indication

Mannitol, the active ingredient in ARIDOL, is a sugar alcohol indicated for the assessment of bronchial hyperresponsiveness in patients 6 years of age or older who do not have clinically apparent asthma.  

ARIDOL is not a stand alone test or a screening test for asthma.  Bronchial challenge testing with ARIDOL should be used only as part of a physician's overall assessment of asthma.

Important Safety Information

WARNING: RISK OF SEVERE BRONCHOSPASM

Mannitol, the active ingredient in ARIDOL, acts as a bronchoconstrictor and may cause severe bronchospasm.  Bronchial challenge testing with ARIDOL is for diagnostic purposes only.  Bronchial challenge testing with ARIDOL should only be conducted by trained professionals under the supervision of a physician familiar with all aspects of the bronchial challenge test and the management of acute bronchospasm. Medications (such as short acting inh
'/>"/>

SOURCE Pharmaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
2. Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
3. FDA Approves Pharmaxis ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
4. Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
5. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
6. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
7. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
8. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
9. Pharmaxis Establishes Named Patient Program for Bronchitol
10. Pharmaxis Long-Term Safety Study of Bronchitol Completes
11. Healthpoint Launches New Corporate Identity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/rt3mhz/deciphering ... "Deciphering Global Major Pharmaceutical Companies, New Outsourcing Demands ... It has been publicly recognized that global ... series of challenges in the recent years. The ... in small molecule product manufacturing; increasingly challenging process ...
(Date:7/7/2015)... 7, 2015   Decision Resources Group ... dialysis patient management in the U.S. versus the ... U.S. and EU5 nephrologists from approximately 1,870 dialysis ... the most commonly used renal medications in dialysis ... considerably between the two regions.      Other ...
(Date:7/7/2015)... BANGALORE , July 7, 2015 ... innovative clinical trial data management solutions, has been featured ... publication named " EDC and eCOA / ePRO Market ... is one of the leading providers of research and ... 22 EDC and eCOA / ePRO tools in the ...
Breaking Medicine Technology:Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
... Minimally Invasive Surgery Symposium (MISS) will include discussion of ... surgery, single-port bariatric surgery, transoral gastroplasty, and other "frontier" ... by MISS Executive Director Philip R Schauer, MD, on ... , The five-day CME conference, which will be held ...
... Oct. 27 Endologix, Inc. (Nasdaq: ... disorders, today announced financial results for the three and ... McDermott, Endologix President and Chief Executive Officer, said, "Our ... sales of new products by our domestic sales force ...
Cached Medicine Technology:Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego 2Endologix Reports 47% Third Quarter 2009 Revenue Growth 2Endologix Reports 47% Third Quarter 2009 Revenue Growth 3Endologix Reports 47% Third Quarter 2009 Revenue Growth 4Endologix Reports 47% Third Quarter 2009 Revenue Growth 5Endologix Reports 47% Third Quarter 2009 Revenue Growth 6Endologix Reports 47% Third Quarter 2009 Revenue Growth 7Endologix Reports 47% Third Quarter 2009 Revenue Growth 8
(Date:7/7/2015)... ... 07, 2015 , ... This week Northeast Nebraska Imaging, Norfolk’s ... The website’s goal is to provide patients with detailed information about the various ... appointments online. , Part of the center’s rebranding efforts, the website was designed ...
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers for Disease ... Massachusetts , and the Multicultural AIDS Coalition $3.78 million for a five-year ... sex with men (MSM) and transgender women, the groups at highest risk of ...
(Date:7/7/2015)... ... ... Quadrino Law Group is pleased to announce the relocation of the firm's headquarters to ... is a state of the art building, located with easy access to New York ... said, "We are pleased to service our clients from such a premier location and ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... provider of advanced delivery technologies and development solutions for drugs, biologics and ... agreement with Excelimmune, Inc. to access its antibody combination therapy (ACT) technology ...
(Date:7/7/2015)... LINCOLN, R.I. (PRWEB) , ... July 07, 2015 , ... ... take the proper precautions, however, so Amica Insurance is sharing some safety tips. , ... activities, sports and gardening: , Leisure activities/sports, , Start slowly. ...
Breaking Medicine News(10 mins):Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Amica Insurance Has 7 Summer Safety Tips 2
... By Maryann Mott HealthDay Reporter , FRIDAY, March ... workers spent nearly 10 hours removing hundreds of sick and ... of the United States, larger animal-hoarding cases. More than ... and rabbits to dogs and cats -- had been living ...
... Most people want to take responsibility for their health but ... a new survey. The statewide poll of Pennsylvania adults ... believe they are more responsible for their personal health than ... and 2.3 percent didn,t know. The survey also found ...
... Approximately five percent of prescriptions submitted by CVS Caremark ... during 2009 included a "dispense as written" (DAW) designation. ... dispensing of a specific brand-name drug and not a ... to $7.7 billion annually, according to a new study ...
... for Cancer Research (AACR) announced today that Carey Anders, ... UNC Lineberger Comprehensive Cancer Center will receive a Breast ... The $181,000 grant will be presented at the ... Florida, April 2-6. The grant will fund laboratory ...
... (HealthDay News) -- A poor diet is associated with a ... study has found. Researchers analyzed data from 72,833 older ... more than a single nutrient were associated with a 21 ... with deficiencies in three nutrients. Women with anemia consumed ...
... ORLANDO, Fla. The American Association for Cancer Research ... will present three INNOVATOR Awards at the AACR 102nd ... Annual Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research ... assistant professor in the department of obstetrics, gynecology and ...
Cached Medicine News:Health News:Animal 'Hoarding' Often Tied to Mental Illness 2Health News:Animal 'Hoarding' Often Tied to Mental Illness 3Health News:Animal 'Hoarding' Often Tied to Mental Illness 4Health News:Research finds 'dispense as written' prescriptions may add $7.7 billion to annual health care costs 2Health News:UNC physician-scientist receives grant to study breast cancer brain metastases 2Health News:Poor Eating Habits May Lead to Anemia in Older Women 2Health News:AACR and Landon Foundation support the next generation of researchers with INNOVATOR Awards 2Health News:AACR and Landon Foundation support the next generation of researchers with INNOVATOR Awards 3Health News:AACR and Landon Foundation support the next generation of researchers with INNOVATOR Awards 4Health News:AACR and Landon Foundation support the next generation of researchers with INNOVATOR Awards 5
... The Stabilizing Ankle support features ... which lock the calcaneus into ... eversion and inversion. The full-circumference ... and stability. Ideal for chronic ...
... Wee Walker Pediatric Boot is ... pediatric boot that offers superior ... Only two sizes are offered ... sizes will fit left or ...
... Boot is designed as a flexible ... the mid-tibia or fibula to mid-foot ... support. The Bledsoe EZ Set PTB ... motion from 20 degrees of dorsi-flexion ...
... as a flexible and attractive alternative to casting ... and also for second and third degree ankle ... Bledsoe Hi-Top Boot but offers similar support. The ... range of motion from 20 degrees of dorsi-flexion ...
Medicine Products: